S2k guideline for the treatment of hidradenitis suppurativa / acne inversa – Short version
JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 2024-06 · 22 (6) · 868-889
DOI: 10.1111/ddg.15412 ↗Kurz gefasst
Leitlinie in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, online erschienen am 21.05.2024. Verfasst von Christos C Zouboulis und 19 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Dermatology, Venereology, Allergology and Immunology, Staedtisches Klinikum Dessau, Brandenburg Medical School Theodor Fontane and Fac…. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 182 Literaturangaben.
Abstract (Originalsprache)
The S2k guideline on hidradenitis suppurativa/acne inversa (HS/AI) aims to provide an accepted decision aid for the selection/implementation of appropriate/sufficient therapy. HS/AI is a chronic recurrent, inflammatory, potentially mutilating skin disease of the terminal hair follicle‐glandular apparatus, with painful, inflammatory lesions in the apocrine gland‐rich regions of the body. Its point prevalence in Germany is 0.3%, it is diagnosed with a delay of 10.0 ± 9.6 years. Abnormal differentiation of the keratinocytes of the hair follicle‐gland apparatus and accompanying inflammation form the central pathogenetic basis. Primary HS/AI lesions are inflammatory nodules, abscesses and draining tunnels. Recurrences in the last 6 months with at least 2 lesions at the predilection sites point to HS/AI with a 97% accuracy. HS/AI patients suffer from a significant reduction in quality of life. For correct treatment decisions, classification and activity assessment should be done with a validated tool, such as the International Hidradenitis Suppurativa Severity Scoring System (IHS4). HS/AI is classified into two forms according to the degree of detectable inflammation: active, inflammatory (mild, moderate, and severe according to IHS4) and predominantly inactive, non‐inflammatory (Hurley grade I, II and III) HS/AI. Oral tetracyclines or 5‐day intravenous therapy with clindamycin are equal to the effectiveness of clindamycin/rifampicin. Subcutaneously administered adalimumab, secukinumab and bimekizumab are approved for the therapy of HS/AI. Various surgical procedures are available for the predominantly non‐inflammatory disease form. Drug/surgical combinations are considered a holistic therapy method.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Dermatology, Venereology, Allergology and Immunology, Staedtisches Klinikum Dessau, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences Brandenburg, Dessau, Germany.
- Hidradenitis Suppurativa Foundation e.V., Dessau, Germany.
- Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum, Bochum, Germany.
- Dermatology and Laser Consultation Center, Landau, Germany.
- Dermatology II, Colentina Clinical Hospital, Carol-Davila University of Medicine and Pharmacy, Bucharest, Romania.
- Department of Dermatology, Venereology and Allergology, Würzburg University Hospital, Würzburg, Germany.
ORCID-Profile: Christos C Zouboulis, Matthias Goebeler
Zitieren
APA
Zouboulis, C. C., Bechara, F. G., Fritz, K., Goebeler, M., Hetzer, F. H., Just, E., Kirsten, N., Kokolakis, G., Kurzen, H., Nikolakis, G., Pinter, A., Podda, M., Rosinski, K., Schneider-Burrus, S., Taube, K. M., Volz, T., Winkler, T., Kristandt, A., Presser, D., & Zouboulis, V. A. (2024). S2k guideline for the treatment of hidradenitis suppurativa / acne inversa – Short version. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 22(6), 868-889. https://doi.org/10.1111/ddg.15412
Vancouver
Zouboulis CC, Bechara FG, Fritz K, Goebeler M, Hetzer FH, Just E, et al. S2k guideline for the treatment of hidradenitis suppurativa / acne inversa – Short version. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2024;22(6):868-889. doi:10.1111/ddg.15412
BibTeX
@article{Zouboulis2024,
author = {Zouboulis, Christos C and Bechara, Falk G and Fritz, Klaus and Goebeler, Matthias and Hetzer, Frank H and Just, Elke and Kirsten, Natalia and Kokolakis, Georgios and Kurzen, Hjalmar and Nikolakis, Georgios and Pinter, Andreas and Podda, Maurizio and Rosinski, Kerstin and Schneider-Burrus, Sylke and Taube, Klaus-M and Volz, Thomas and Winkler, Thomas and Kristandt, Anna and Presser, Dagmar and Zouboulis, Viktor A},
title = {S2k guideline for the treatment of hidradenitis suppurativa / acne inversa – Short version},
journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
year = {2024},
volume = {22},
number = {6},
pages = {868--889},
doi = {10.1111/ddg.15412}
}
EUVIMED